(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202109 | 202009 | % Var | 202109 | 202009 | % Var | 202103 | 202003 | % Var | |
| Sales | 28701.70 | 30426.00 | -5.67 | 61842.90 | 57376.80 | 7.78 | 110559.30 | 110256.60 | 0.27 |
| Other Income | 746.80 | 252.90 | 195.29 | 1263.60 | 593.00 | 113.09 | 1290.90 | 4751.90 | -72.83 |
| PBIDT | -13242.70 | 6230.70 | -312.54 | -3347.20 | 12523.80 | -126.73 | 21731.50 | 23828.00 | -8.80 |
| Interest | 182.60 | 91.30 | 100.00 | 330.80 | 178.10 | 85.74 | 406.20 | 525.90 | -22.76 |
| PBDT | -13425.30 | 6139.40 | -318.67 | -3678.00 | 12345.70 | -129.79 | 21325.30 | 15710.00 | 35.74 |
| Depreciation | 1299.00 | 1256.00 | 3.42 | 2552.60 | 2507.40 | 1.80 | 5028.30 | 5187.50 | -3.07 |
| PBT | -14724.30 | 4883.40 | -401.52 | -6230.60 | 9838.30 | -163.33 | 16297.00 | 10522.50 | 54.88 |
| TAX | -1433.10 | 1279.10 | -212.04 | 601.90 | 2598.20 | -76.83 | 3710.80 | 3247.00 | 14.28 |
| Deferred Tax | 1760.30 | -20.30 | -8771.43 | 1729.70 | -73.80 | -2443.77 | 82.30 | -373.50 | -122.03 |
| PAT | -13291.20 | 3604.30 | -468.76 | -6832.50 | 7240.10 | -194.37 | 12586.20 | 7275.50 | 72.99 |
| Equity | 908.10 | 906.50 | 0.18 | 908.10 | 906.50 | 0.18 | 907.40 | 906.00 | 0.15 |
| PBIDTM(%) | -46.14 | 20.48 | -325.31 | -5.41 | 21.83 | -124.80 | 19.66 | 21.61 | -9.05 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1904.65 |
| Dr. Reddys Labs. | 1374.55 |
| Cipla | 1458.45 |
| Zydus Lifesciences | 1141.00 |
| Lupin | 2476.10 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: